VSee Health, Inc. (NASDAQ:VSEE) Sees Significant Increase in Short Interest

VSee Health, Inc. (NASDAQ:VSEE – Get Free Report) was the recipient of a large growth in short interest in the month of July. As of July 31st, there was short interest totaling 7,318,494 shares, a growth of 344.2% from the July 15th total of 1,647,591 shares. Based on an average trading volume of 21,913,840 shares, the short-interest ratio is currently 0.3 days. Currently, 203.3% of the company’s stock are sold short.

Hedge Funds Weigh In On VSee Health

An institutional investor recently bought a new stake in VSee Health stock. Virtu Financial LLC acquired a new stake in shares of VSee Health, Inc. (NASDAQ:VSEE – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 66,489 shares of the company’s stock, valued at approximately $25,000. 1.01% of the stock is owned by institutional investors.

Get VSee Health alerts:

VSee Health Stock Down 26.3%

Shares of VSee Health stock traded down $0.01 during midday trading on Thursday, hitting $0.03. The company had a trading volume of 2,972,092 shares, compared to its average volume of 4,158,484. VSee Health has a 52-week low of $0.01 and a 52-week high of $2.52. The company has a debt-to-equity ratio of 0.12, a quick ratio of 0.41 and a current ratio of 0.41. The stock has a market capitalization of $106,200.00 and a P/E ratio of -0.05. The company has a 50 day moving average of $0.10 and a 200 day moving average of $0.20.

VSee Health (NASDAQ:VSEE – Get Free Report) last announced its quarterly earnings data on Friday, May 15th. The company reported ($0.05) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.11) by $0.06. VSee Health had a negative return on equity of 11,636.34% and a negative net margin of 92.36%.The business had revenue of $3.16 million during the quarter, compared to analysts’ expectations of $4.80 million.

Wall Street Analyst Weigh In

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of VSee Health in a research report on Friday, July 17th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, VSee Health currently has an average rating of “Sell”.

Read Our Latest Research Report on VSEE

VSee Health Company Profile

(Get Free Report)

VSee Health is a telehealth technology company that develops secure, HIPAA-compliant software solutions for virtual care. The company’s flagship platform offers high-definition video visits, real-time messaging and collaboration tools designed to streamline remote consultations between patients and healthcare providers. VSee’s solutions are built to integrate with electronic health record systems and include features such as digital waiting rooms, screen sharing and file transfer capabilities.

In addition to video conferencing, VSee Health provides remote patient monitoring (RPM) tools that enable clinicians to collect biometric data, such as blood pressure, heart rate and glucose readings, from patients in their homes.

Featured Stories

• Five stocks we like better than VSee Health
• Asian Market Circuit Breakers Hit Stocks, Not AI Demand
• Riot Platforms Re-Wires the Ledger for a $9B AI Power Play
• Nebius Just Exploded 34% on Blowout Earnings—Is It Time to Buy?
• Joby’s Defense Pivot Accelerates With $500M Resonant Sciences Deal

Receive News & Ratings for VSee Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VSee Health and related companies with MarketBeat.com's FREE daily email newsletter.